Contact
210-562-5844For administrative calls, please contact:
Programs
Departments & Divisions
Research
Currently not seeking mentees
Professor of Pediatrics
Chief, Division of Pulmonology
Miss Eloise Alexander Distinguished University Chair in Pediatric Pulmonology
Center Director and Pediatric Program Director for The University of Texas Health Science Center Cystic Fibrosis Center
The primary focus of my research, clinical, and teaching roles involves the management of patients with cystic fibrosis. I founded the Cystic Fibrosis Center at the University of Texas Health Science Center in 2014 and serve as both the Center and Pediatric Program Directors. In my role, I provide education to medical students, residents, and fellows about the pathophysiology and care of patients with cystic fibrosis. I worked with the Texas Department of State Health Services to develop the algorithm to add cystic fibrosis to the Texas newborn screening panel and oversee the cystic fibrosis newborn screening program at University Hospital. I have been engaged with the managment of pediatric patients with cystic fibrosis including providing clinical care as well as serving as the principal investigator for numerous clinical trials of new therapies aimed at enhancing the pulmonary health and survival of patients with cystic fibrosis. I have been engaged in quality improvement work related to cystic fibrosis both within my own Center as well as serving as a national quailty improvement coach for the Cystic Fibrosis Foundation. Additionally, I have been invovled with the Cystic Fibrosis Foundation serving on committees to write guidelines for cystic fibrosis care, serving as a Center Committe member, and leading a taskforce to enhance the education and training of new program directors. Locally, I work with the Lone Star Cystic Fibrosis Chapter on various fund raising activities and provide education to the public on cystic fibrosis.
I have served as the local principal investigator for numerous clinical trials of novel pulmonary therapies designed to enhance the lung function and survival of patients with cystic fibrosis.
Funding Agency Cystic Fibrosis Foundation Title Award for Mental Health Coordinator (CMHC310-16) Status Active Period 1/2018 - 12/2018 Role Co-Investigator Grant Detail Implementation of the Depression Anxiety Guidelines: Award for Mental Health Coordinator. This award is designed to facilitate implementation of the depression and anxiety guideline recommendations. The focus of this Request for Applications is to provide seed funding for a CF Mental Health Coordinator to implement annual screening and follow-up; coordinate evidence-based treatment for depression and anxiety; develop and maintain a referral network of community-based mental health care in CF for the CF Center, hospital or institution, community practitioner, and payers. Funding Agency Cystic Fibrosis Foundation Title Award for Mental Health Coordinator (CMHC310-16) Status Active Period 1/2017 - 12/2017 Role Principal Investigator Grant Detail Implementation of the Depression Anxiety Guidelines: Award for Mental Health Coordinator. This award is designed to facilitate implementation of the depression and anxiety guideline recommendations. The focus of this Request for Applications is to provide seed funding for a CF Mental Health Coordinator to implement annual screening and follow-up; coordinate evidence-based treatment for depression and anxiety; develop and maintain a referral network of community-based mental health care in CF for the CF Center, hospital or institution, community practitioner, and payers. Funding Agency Cystic Fibrosis Foundation Title Award for Physical Therapist (CCPT310-16) Status Active Period 11/2016 - 10/2017 Role Principal Investigator Grant Detail This award is designed to facilitate recruitment of an outpatient physical therapist (PT) as a member of the multidisciplinary CF clinic team. The focus of this Request for Application sis to catalyze recruitment of a PT to use the best available evidence ti implement annual screening, recommendations, and referrals for issues related to cardio-respiratory and musculoskeletal fitness, as it relates to airway clearance, healthy physical activity and exercise. The CF PT will also develop and implement processes to help prevent disease and inactivity related problems in clinic population, serve as a resource to the multidisciplinary team and physical therapist outside the clinic, and advocate for physical therapy issues within the larger CF community. Funding Agency Cystic Fibrosis Foundation Title Cystic Fibrosis Center Grant (CC310-16) Status Complete Period 7/2016 - 7/2017 Role Principal Investigator Grant Detail Grant provided annually by the North American Cystic Fibrosis Foundation to the UTHSCSA Cystic Fibrosis Care Center at the Robert B. Green Clinical Pavilion / University Health System. Funding used for salary support as well as to cover other center costs including attendance at the National CF Conference. Funding Agency Cystic Fibrosis Foundation Title Cystic Fibrosis Center Grant (CC310-15) Status Complete Period 7/2015 - 7/2016 Role Principal Investigator Grant Detail Grant provided annually by the North American Cystic Fibrosis Foundation to the UTHSCSA Cystic Fibrosis Care Center at the Robert B. Green Clinical Pavilion / University Health System. Funding used for salary support as well as to cover other center costs including attendance at the National CF Conference.
Funding Agency Texas Dept. of State Health Services Title CSHCN Services Program UTHSCSA Cystic Fibrosis Center Status Complete Period 9/2015 - 8/2016 Role Principal Investigator Grant Detail Grant provided by the Texas Dept. of State Health Services / Children with Special Health Care Needs to the UTHSCSA Cystic Fibrosis Center for case management as well as development of the CF Center as a medical home.
Chief of the Pediatric Pulmonary Division
Center Director and Peditric Program Director, University of Texas Health Science Center Cystic Fibrosis Center
Faculty Mentor
Pharmacy and Therpeutic Pulmonary Subcommittee
Cystic Fibrosis Foundation:
1. Member, Center Committe
2. Leader, New Program Director Takforce
3. Member of the Pulmonary and CFTR Modulator Clinical Practice Guidelines Subcommittees
4. Representative from Texas to the CFF Newborn Screening Quality Improvement Consortium
I have served as a board member for the Lone Star Cystic Fibrosis Chapter and participate in local fund raising events as well as providing education to increase cystic fibrosis awareness.
Willey-Courand DB. Cystic Fibrosis. In: Marshall BC, McInerny TK, Adam HM, Campbell DE, DeWill TG, Foy JM, Kamat DM, eds. Pediatric Primary Care. Elk Grove Village, IL; 2017.
Clement L. Ren, Rebecca L. Morgan, Christopher Oermann, Helaine E. Resnick, Cynthia Brady, Annette Campbell, Richard DeNagel, Margaret Guill, Jeffrey Hoag, Andrew Lipton, Thomas Newton, Stacy Peters, Donna Beth Willey-Courand, and Edward T. Naureckas. Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis Ann Am Thorac Soc 2018 Mar;15(3):271-280.
Rayas MS, Willey-Courand DB, Lynch JL, Guajardo JR. Improved Screening for Cystic Fibrosis-Related Diabetes by an Integrated Care Team Using an Algorithm Pediatric Pulmonology 2014 Oct;49(10):971-977.
Brown RF, Willey-Courand DB, George C, McMullen A, Duntz J, Solvis B, Perkett E. Non-Physician Providers as Clinical Providers in Cystic Fibrosis: Survey of US Programs; Pediatric Pulmonology 2013 Apr;4(48):398-404.